Rational design and synthesis of a novel, selective class of thrombin inhibitors: P-1-argininal derivatives incorporating P-3-P-4 quaternary lactam dipeptide surrogates

被引:21
作者
Semple, JE
Minami, NK
Tamura, SY
Brunck, TK
Nutt, RF
Ripka, WC
机构
[1] Department of Medicinal Chemistry, Corvas International, Inc., San Diego, CA 92121
关键词
D O I
10.1016/S0960-894X(97)00446-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SAR and molecular modeling investigations on the potent and selective thrombin inhibitor 1b (CVS 1578) and related serine protease inhibitors led to the design of series 2a-g, featuring quaternary alpha-amino-alpha-benzyl-lactam scaffolds that serve as novel P-3-P-4 dipeptide mimics. The design, synthesis, and biological activity of these targets are presented. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:2421 / 2426
页数:6
相关论文
共 31 条
[1]   Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures [J].
AbdelMagid, AF ;
Carson, KG ;
Harris, BD ;
Maryanoff, CA ;
Shah, RD .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (11) :3849-3862
[2]  
ABDELMAGID AF, 1994, SYNLETT, P81
[3]   RACEMIZATION STUDIES DURING SOLID-PHASE PEPTIDE-SYNTHESIS USING AZABENZOTRIAZOLE-BASED COUPLING REAGENTS [J].
CARPINO, LA ;
EL-FAHAM, A ;
ALBERICIO, F .
TETRAHEDRON LETTERS, 1994, 35 (15) :2279-2282
[4]   1-HYDROXY-7-AZABENZOTRIAZOLE - AN EFFICIENT PEPTIDE COUPLING ADDITIVE [J].
CARPINO, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (10) :4397-4398
[5]   DESIGN AND SYNTHESIS OF A CONFORMATIONALLY RESTRICTED CYSTEINE PROTEASE INHIBITOR [J].
CHENG, HM ;
KEITZ, P ;
JONES, JB .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (25) :7671-7676
[6]   CONFORMATIONALLY CONSTRAINED DIPEPTIDES - SYNTHESIS OF 7,5-FUSED AND 6,5-FUSED BICYCLIC LACTAMS BY STEREOSELECTIVE RADICAL CYCLIZATIONS [J].
COLOMBO, L ;
DIGIACOMO, M ;
SCOLASTICO, C ;
MANZONI, L ;
BELVISI, L ;
MOLTENI, V .
TETRAHEDRON LETTERS, 1995, 36 (04) :625-628
[7]   Potent thrombin inhibitors that probe the S-1' subsite: Tripeptide transition state analogues based on a heterocycle-activated carbonyl group [J].
Costanzo, MJ ;
Maryanoff, BE ;
Hecker, LR ;
Schott, MR ;
Yabut, SC ;
Zhang, HC ;
AndradeGordon, P ;
Kauffman, JA ;
Lewis, JM ;
Krishnan, R ;
Tulinsky, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3039-3043
[8]   S-1 heterocyclic thrombin inhibitors [J].
Dominguez, C ;
Carini, DJ ;
Weber, PC ;
Knabb, RM ;
Alexander, RS ;
Kettner, CA ;
Wexler, RR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (01) :79-84
[9]   Thrombin and factor Xa inhibition [J].
Edmunds, JJ ;
Rapundalo, ST ;
Siddiqui, MA .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 :51-60
[10]   Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: Implications for drug design [J].
Engh, RA ;
Brandstetter, H ;
Sucher, G ;
Eichinger, A ;
Baumann, U ;
Bode, W ;
Huber, R ;
Poll, T ;
Rudolph, R ;
vonderSaal, W .
STRUCTURE, 1996, 4 (11) :1353-1362